Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Expand Energy (EXEEW) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Expand Energy (EXEEW) over the last 17 years, with Q3 2025 value amounting to $613.0 million.

  • Expand Energy's Cash & Equivalents fell 4128.35% to $613.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $613.0 million, marking a year-over-year decrease of 4128.35%. This contributed to the annual value of $317.0 million for FY2024, which is 7062.09% down from last year.
  • Per Expand Energy's latest filing, its Cash & Equivalents stood at $613.0 million for Q3 2025, which was down 4128.35% from $731.0 million recorded in Q2 2025.
  • In the past 5 years, Expand Energy's Cash & Equivalents registered a high of $1.2 billion during Q1 2024, and its lowest value of $17.0 million during Q2 2022.
  • For the 5-year period, Expand Energy's Cash & Equivalents averaged around $580.2 million, with its median value being $613.0 million (2025).
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 9722.22% in 2022, then soared by 521176.47% in 2023.
  • Expand Energy's Cash & Equivalents (Quarter) stood at $905.0 million in 2021, then tumbled by 85.64% to $130.0 million in 2022, then skyrocketed by 730.0% to $1.1 billion in 2023, then plummeted by 70.62% to $317.0 million in 2024, then skyrocketed by 93.38% to $613.0 million in 2025.
  • Its Cash & Equivalents was $613.0 million in Q3 2025, compared to $731.0 million in Q2 2025 and $349.0 million in Q1 2025.